Understanding how MLLT3 affects blood cell formation and leukemia.
AF9(MLLT3) Function in Leukemia and Normal Hematopoiesis
This study is looking at a protein called MLLT3 to understand how it helps make blood cells and how it might be linked to leukemia, with the hope of finding new ways to treat this condition for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10738333 on NIH RePORTER |
What this research studies
This research investigates the role of the MLLT3 protein in the formation of blood cells and its involvement in leukemia. By examining how MLLT3 interacts with other proteins and genes, the study aims to uncover the mechanisms that regulate blood cell production and the development of leukemia. The research utilizes advanced techniques to analyze protein structures and their functions, which could lead to new insights into blood disorders. Patients may benefit from a better understanding of leukemia and potential new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with leukemia or those with conditions affecting blood cell formation.
Not a fit: Patients with non-hematological conditions or those not affected by blood disorders may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for leukemia and other blood disorders.
How similar studies have performed: Previous research has shown promising results in understanding the roles of similar proteins in leukemia, indicating that this approach has potential for success.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Bushweller, John Hackett — University of Virginia
- Study coordinator: Bushweller, John Hackett
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.